In our Case of the Week, the Federal Circuit revisited and clarified the “demanding standard for judicial correction via claim construction,” which permits a court in narrow circumstances to modify claim language to correct...more
11/18/2025
/ CAFC ,
Claim Construction ,
Energy Sector ,
Indefiniteness ,
Intellectual Property Litigation ,
Modification ,
Oil & Gas ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patents ,
Technical Errors
Our case of the week is one of a series of cases challenging newly-enacted procedures by the Trump Administration that are having a significant effect on the inter partes review regime set up by the America Invents Act. In a...more
11/11/2025
/ Administrative Procedure Act ,
America Invents Act ,
Appeals ,
Inter Partes Review (IPR) Proceeding ,
Mandamus Petitions ,
Motorola ,
Patent Trial and Appeal Board ,
Patents ,
Regulatory Reform ,
Trump Administration ,
USPTO
Merck Serono S.A. v. Hopewell Pharma Ventures, Inc., Appeal Nos. 2025-1210, -1211 (Fed. Cir. Oct. 30, 2025) -
In our Case of the Week, the Federal Circuit upheld a Patent Trial and Appeal Board decision invalidating...more
11/4/2025
/ Appeals ,
Claim Construction ,
Inter Partes Review (IPR) Proceeding ,
Merck ,
Noninfringement ,
Obviousness ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prior Art
Centripetal Networks, LLC v. Palo Alto Networks, Inc. et al., Appeal No. 2023-2027 (Fed. Cir. Oct. 22, 2025) -
In the Court’s only precedential opinion last week, a panel of the Federal Circuit considered issues...more
10/28/2025
/ Administrative Law Judge (ALJ) ,
CAFC ,
Due Process ,
Inter Partes Review (IPR) Proceeding ,
Jurisdiction ,
Obviousness ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Precedential Opinion ,
Recusal ,
Statutory Interpretation
Rex Medical, L.P. v. Intuitive Surgical, Inc., Appeal Nos. 2024-1072, -1125 (Fed. Cir. Oct. 2, 2025)
In this week’s Case of the Week, Rex Medical, L.P. (“Rex”) appeals from a decision out of the U.S. District Court for...more
10/7/2025
/ Administrative Procedure Act ,
Appeals ,
Damages ,
Expert Testimony ,
Inter Partes Review (IPR) Proceeding ,
Jury Awards ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Standing ,
USPTO
Finesse Wireless LLC v. AT&T Mobility LLC, Appeal No. 2024-1039 (Fed. Cir. Sept. 24, 2025) -
In our Case of the Week, the Federal Circuit struck down a $166.3 million damages award against AT&T and Nokia of America Corp.,...more
9/30/2025
/ Appeals ,
AT&T ,
CAFC ,
Claim Construction ,
Damages ,
Evidence ,
Inter Partes Review (IPR) Proceeding ,
JMOL ,
Jury Verdicts ,
Nokia ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent Validity ,
Pharmaceutical Patents ,
Vacated
Global Health Solutions LLC v. Selner, Appeal No. 2023-2009 (Fed. Cir. Aug. 26, 2025) -
In our Case of the Week, the Federal Circuit conducted its first review of a derivation proceeding under the America Invents Act that...more
9/3/2025
/ America Invents Act ,
Appeals ,
Derivation Proceeding ,
First-to-File ,
Inventions ,
Inventors ,
Laches ,
Patent Applications ,
Patent Litigation ,
Patent Prosecution ,
Patent Trial and Appeal Board
Laboratory Corporation of America Holdings v. Qiagen Sciences, LLC, Appeal No. 2023-2350 (Fed. Cir. Aug. 13, 2025) -
In our Case of the Week, the Federal Circuit reversed a jury finding of infringement from the District...more
8/19/2025
/ Appeals ,
CAFC ,
Calculation of Damages ,
Claim Construction ,
Damages ,
Doctrine of Equivalents ,
Jury Trial ,
Motion for JMOL ,
Patent Infringement ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Reversal
Mondis Tech. Ltd. v. LG Electronics Inc., Appeal Nos. 2023-2117, -2116 (Fed. Cir. Aug. 8, 2025)
Our Case of the Week focuses on the written description requirement, and, in particular, how that requirement is considered...more
Jiaxing Super Lighting Electric Appliance, Co. Ltd. v. CH Lighting Technology Co., Ltd., Appeal No. 2023-1715 (Fed. Cir. July 28, 2025)
In our Case of the Week, the Federal Circuit addressed three issues arising from a...more
8/5/2025
/ Appeals ,
CAFC ,
Damages ,
Daubert Standards ,
Expert Testimony ,
Intellectual Property Litigation ,
Inter Partes Review (IPR) Proceeding ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patents ,
Royalties
IGT v. Zynga Inc., Appeal No. 2023-2262 (Fed. Cir. July 22, 2025)
In this week’s Case of the Week, the Federal Circuit examined the reviewability and merits of the Patent Trial Appeal Board’s decision to institute inter...more
Top Brand LLC v. Cozy Comfort Company LLC, Appeal No. 2024-2191 (Fed. Cir. July 17, 2025)
In this week’s Case of the Week, the Court of Appeals for the Federal Circuit held that prosecution history disclaimer applies to...more
7/22/2025
/ Appeals ,
Damages ,
Design Patent ,
JMOL ,
Noninfringement ,
Patent Litigation ,
Patents ,
Prosecution History Estoppel ,
Trademark Infringement ,
Trademark Litigation ,
USPTO
Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc., Appeal Nos. 2025-1228, -1252 (Fed. Cir. July 8, 2025)
Our Case of the Week focuses on obviousness. More particularly, the decision included a lengthy...more
Eye Therapies, LLC v. Slayback Pharma, LLC, Appeal No. 2023-2173 (Fed. Cir. June 30, 2025)
In its only precedential patent opinion last week, the Federal Circuit reviewed construction of the transitional claim phrase...more
Optis Cellular Technology, LLC v. Apple Inc., Appeal Nos. 2022-1904, -1925 (Fed. Cir. June 16, 2025)
In this week’s Case of the Week, the Court of Appeals for the Federal Circuit vacated a jury decision awarding...more
Mitek Systems Inc. v. United Services Automobile Association, Appeal No. 2023-1687 (Fed. Cir. June 12, 2025)
In our Case of the Week, the Federal Circuit examined the limits of declaratory judgment jurisdiction for a...more
6/16/2025
/ Appeals ,
CRISPR ,
Declaratory Judgments ,
Intellectual Property Litigation ,
Jurisdiction ,
Patent Infringement ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Prior Art ,
Section 101 ,
Section 112 ,
Summary Judgment ,
Technology
Alnylam Pharmaceuticals, Inc. v. Moderna, Inc., Appeal No. 2023-2357 (Fed. Cir. June 4, 2025)
In this week’s Case of the Week, the Federal Circuit affirmed a final judgment that Moderna’s mRNA-based COVID-19 vaccine did...more
6/9/2025
/ Appeals ,
Article III ,
Claim Construction ,
Inter Partes Review (IPR) Proceeding ,
Life Sciences ,
Noninfringement ,
Patent Infringement ,
Patent Litigation ,
Patent Validity ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Standing
EcoFactor, Inc. v. Google LLC, Appeal No. 2023-1101 (Fed. Cir. May 21, 2025)
In its first en banc decision of the year, the Federal Circuit reversed a district court’s admission of expert testimony concerning damages,...more
5/28/2025
/ Appeals ,
Claim Construction ,
Damages ,
Daubert Standards ,
Expert Testimony ,
Motion for JMOL ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Reversal ,
Rule of Evidence 702
The Regents of the University of California v. The Broad Institute, Inc., Appeal Nos. 2022-1594, -1653 (Fed. Cir. May 12, 2025)
Must an inventor know their invention will work to demonstrate that they “conceived” of it? ...more
This week, we take a closer look at two precedential cases concerning pharmaceutical patent protections as applied to drugs in development.
In Incyte Corp. v. Sun Pharm., Judge Hughes entered a dissent pushing back on the...more
5/13/2025
/ Appeals ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Hatch-Waxman ,
Injunctive Relief ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Remand ,
USPTO
State and local governments: Do your websites and mobile apps meet accessibility standards?
The compliance dates for DOJ’s digital accessibility requirements are coming soon!
Title II of the Americans with Disabilities Act...more
Fintiv, Inc. v. Paypal holdings, Inc., Appeal No. 2023-2312 (Fed. Cir. Apr. 30, 2025)
In its only precedential patent opinion last week, the Federal Circuit affirmed a district court’s determination that the terms “payment...more
5/6/2025
/ Algorithms ,
America Invents Act ,
Appeals ,
Claim Construction ,
FinTech ,
Indefiniteness ,
Intellectual Property Litigation ,
Means-Plus-Function ,
Patent Invalidity ,
Patent Litigation ,
Patents
Qualcomm Inc. v. Apple Inc., Appeal Nos. 2023-1208, -1209 (Fed. Cir. Apr. 23, 2025) -
For a second time in this case, the Federal Circuit considered the proper role of “Applicant Admitted Prior Art” in an inter partes...more
Recentive Analytics, Inc., v. Fox Corp., Appeal No. 2023-2437 (Fed. Cir. Apr. 18, 2025)
In our Case of the Week, the Federal Circuit addressed a question of first impression concerning whether developments in machine...more
4/22/2025
/ Algorithms ,
Alice/Mayo ,
Appeals ,
Artificial Intelligence ,
Innovative Technology ,
Intellectual Property Litigation ,
Inter Partes Review (IPR) Proceeding ,
Machine Learning ,
Patent Invalidity ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Prior Art ,
Section 101
Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd., Appeal No. 2023-1977 (Fed. Cir. Apr. 8, 2025)
In our Case of the Week, the Federal Circuit affirmed that defendant Alkem’s proposed generic antibiotic did not...more
4/15/2025
/ Abbreviated New Drug Application (ANDA) ,
Appeals ,
Claim Construction ,
Generic Drugs ,
Hatch-Waxman ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prior Art ,
Writ of Mandamus